NERV (Minerva Neurosciences Corp) Dana dhuwit perusahaan

Logo korporat perusahaan Minerva Neurosciences, Inc. (NERV)

Minerva Neurosciences relies on external CDMO facilities for drug production to minimize manufacturing risks. The current cash position illustrates financial stability, while 0.08 reflects the latest metric value. Stable management aims to overcome FDA hurdles, and the non-cyclical demand for schizophrenia therapy makes the company's success dependent solely on regulatory decisions.

Aset likuid perusahaan: Minerva Neurosciences Inc (NERV) kanggo 04.07.2022 - 21.11.2026

Rincian analitis lan laporan data perusahaan Minerva Neurosciences, Inc. (NERV)

- nilai saham lan prakiraan konsensus rega:
Analisis kabeh metrik perusahaan:NERV Minerva Neurosciences, Inc.
Produk merek minervaneurosciences.com

To minimize fundamental risks, investors should divest from illiquid assets by analyzing the total volume of available cash and cash equivalents. This metric measures real financial stability, allowing the cash history of Minerva Neurosciences (NERV) to track the burn rate during the period of collecting additional clinical data for its schizophrenia drug. A downward trend on this chart signals the depletion of resources amid the suspension of new developments.

Karo sapa Minerva Neurosciences saingan

Volume dana dhuwit perusahaan BIIB|Dana dhuwit perusahaan NBIX (Neurocrine Biosciences)|Dana dhuwit perusahaan Regencell Bioscience Ltd RGC|AXSM (Axsome Therapeutics, Inc.) - Total volume dana dhuwit perusahaan|ACADIA Corp - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Xenon Pharmaceuticals|VKTX (Viking Therapeutics Corp) - Dhuwit awis perusahaan|Supernus Pharmaceuticals (SUPN) - Volume dana dhuwit perusahaan|CPRX (Catalyst Pharma) - Volume dana dhuwit perusahaan|DNLI (Denali Therapeutics Inc.) - Gunggung dana dhuwit perusahaan|Volume dana dhuwit perusahaan HRMY|Biohaven Corp - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan AMLX (amylyx.com)|Aset likuid perusahaan Trevi Therapeutics, Inc. (TRVI)|Praxis Corp - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Anavex|CBLL (CeriBell Inc) - Dhuwit awis perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan PRTA|Dana dhuwit perusahaan Alector Inc.|Cadangan dhuwit perusahaan Annexon, Inc. ANNX|Dana dhuwit perusahaan Omeros Corp (OMER)|NGNE (Neurogene Inc) - Sisa dhuwit perusahaan|Dana dhuwit perusahaan AC Immune Inc ACIU|Posisi dhuwit perusahaan Voyager Corp|Neumora Corp - Volume dana dhuwit perusahaan|scilexholding.com (SCLX) - Dhuwit awis perusahaan|Tevogen Bio Holdings, Inc. (TVGN) - Dana dhuwit perusahaan|Alpha Cognition Corp (ACOG) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan CGTX|Dhuwit awis lan setara dhuwit awis perusahaan IKT (Inhibikase)|Volume dana dhuwit perusahaan SAVA|Assertio - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan COYA (Coya Therapeutics)|Volume dana dhuwit perusahaan Vistagen Therapeutics VTGN|OVID: Dhuwit awis perusahaan|ABOS - Volume dana dhuwit perusahaan|CRVO: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Alterity Therapeutics Ltd. (ATHE)|Dana dhuwit perusahaan Clene Inc.|pepgen.com (PEPG) - Aset likuid perusahaan|Dhuwit awis perusahaan JUNS (jupiterneurosciences.com)|Dana dhuwit perusahaan RLMD (Relmada Corp)|Annovis Bio, Inc. - Dhuwit awis perusahaan|Posisi dhuwit perusahaan Grace Therapeutics, Inc.|Firefly Neuroscience, Inc - Volume dana dhuwit perusahaan|KLTO - Volume dana dhuwit perusahaan|NRSN (NeuroSense Therapeutics Ltd.) - Dhuwit awis perusahaan|RVPH - Aset likuid perusahaan|Dana dhuwit perusahaan MetaVia|Dhuwit awis lan setara dhuwit awis perusahaan NRXS (neuraxis.com)|Dana dhuwit perusahaan Helius Medical Technologies (HSDT)|PASG (Passage Bio) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan NEUP (Neuphoria Therapeutics)|Sisa dhuwit perusahaan ATHA|ADXN - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Alzamend Neuro Inc.|Cyclerion Therapeutics (CYCN) - Dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan PTIX|KTTA (pasitheaclinics.com) - Volume dana dhuwit perusahaan|CRGT (cortigent.com) - Gunggung dana dhuwit perusahaan|Volume dana dhuwit perusahaan ATXI|Dana dhuwit perusahaan BCLI (Brainstorm Cell)|Volume dana dhuwit perusahaan CARA (Cara Therapeutics Inc)|Sisa dhuwit perusahaan CHRO|Eliem Therapeutics Inc. - Volume dana dhuwit perusahaan|ITCI - Volume dana dhuwit perusahaan|Longboard Pharma (LBPH) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Marinus Pharmaceuticals|Dana dhuwit perusahaan NKGen|Volume dana dhuwit perusahaan NeuroBo Pharmaceuticals, Inc.|Volume dana dhuwit perusahaan SAGE|Synaptogenix, Inc - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Trevena TRVN|Posisi dhuwit perusahaan Vigil Neuroscience|Anew Medical Inc. - Volume dana dhuwit perusahaan|Aset likuid perusahaan Cerevel Therapeutics, Inc. CERE